Royce & Associates LP Elanco Animal Health Inc Transaction History
Royce & Associates LP
- $9.25 Billion
- Q2 2025
A detailed history of Royce & Associates LP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Royce & Associates LP holds 496,932 shares of ELAN stock, worth $10.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
496,932Holding current value
$10.3 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
420Shares Held
487MCall Options Held
868KPut Options Held
1.42M-
Dodge & Cox San Francisco, CA82.9MShares$1.71 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$1.07 Billion0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA47.8MShares$988 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$481 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$470 Million0.08% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $9.8B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...